Robert "Bob" Cooper of the L.A. firm Gibson Dunn defended some of the country’s largest and most recognizable companies from ...

Patients with rare diseases are increasingly working to find and fund their own cures. But should they have to?

Pfizer Inc. (NYSE:PFE) ranks among the best set-it-and-forget-it stocks to buy. On June 26, Pfizer Inc. (NYSE:PFE) declared ...

In a recent regulatory development, the Subject Expert Committee (SEC) under the Dermatology and Allergy division of the ...

I didn’t set out to build a global innovation network spanning 45 countries. Here are four lessons from my journey.

Vaccines have been rigorously tested, reviewed, and monitored for decades. They are one of the greatest success stories in ...

The Minister for Health, Kwabena Mintah Akandoh, has met with Mr. Ali Besri, Head of Pfizer's Accord and his team, to strengthen collaboration in advancing equitable and affordable healthcare in Ghana ...

The European Commission has cleared OD-L1 inhibitor Imfinzi (durvalumab) to treat adults with resectable muscle-invasive ...

The combination of climate change and pathogen expansion could be fueling a surge in infectious diseases. GEN consulted ...

The European Commission has cleared OD-L1 inhibitor Imfinzi (durvalumab) to treat adults with resectable muscle-invasive ...

Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...